Results 11 to 20 of about 15,577 (237)
Clinical Infectious Diseases, 2017 Background. Increasing azithromycin usage and resistance in Neisseria gonorrhoeae threatens current dual treatment. Because antimicrobial exposure influences resistance, we analyzed the association between azithromycin exposure and decreased ...
Carolien M Wind +2 more
exaly +2 more sources
The use of Azithromycin and Hydroxychloroquine in the Treatment of Covid-19 [PDF]
SHS Web of Conferences, 2023 This paper mainly studies the therapeutic effect of azithromycin and hydroxychloroquine on COVID-19. Severe acute respiratory syndrome is one of the key clinical manifestations of COVID-19, and azithromycin is considered to be a feasible treatment.
Ma Yue, Lu Jiawei, Qin Si
doaj +1 more source
Microbiology Spectrum, 2023 Azithromycin combined with ceftriaxone is the recommended dual therapy for uncomplicated gonorrhea in many countries. Nevertheless, the increasing prevalence of azithromycin resistance compromises the effectiveness of this treatment strategy.
Ricardo Ariel Gianecini +11 more
doaj +1 more source
Azithromycin and the microbiota of cystic fibrosis sputum
BMC Microbiology, 2021 Background Azithromycin is commonly prescribed drug for individuals with cystic fibrosis (CF), with demonstrated benefits in reducing lung function decline, exacerbation occurrence and improving nutrition.
Nicole Acosta +6 more
doaj +1 more source
The timing of azithromycin treatment is not associated with the clinical prognosis of childhood Mycoplasma pneumoniae pneumonia in high macrolide-resistant prevalence settings. [PDF]
PLoS ONE, 2018 Mycoplasma pneumoniae infection is a major cause of community-acquired pneumonia in children. We performed a retrospective study to evaluate the clinical impact of the timing of azithromycin treatment in children with Mycoplasma pneumoniae pneumonia in ...
Dehua Yang, Linghong Chen, Zhimin Chen
doaj +1 more source
Veterinary Research, 2022 Staphylococcus saprophyticus is frequently involved in various difficult-to-treat infections due to the formation of biofilms. To identify useful antibiofilm strategies, this study explored the efficacy and mechanism of baicalin in enhancing the ability ...
Jinli Wang +12 more
doaj +1 more source
BMC Ophthalmology, 2021 Background The World Health Organization (WHO) recommends annual mass azithromycin distribution until districts drop below 5% prevalence of trachomatous inflammation—follicular (TF).
Abdou Amza +9 more
doaj +1 more source
EFFICACY OF AZITHROMYCIN ON EXPERIMENTAL TOXOPLASMOSIS INFECTED MICE [PDF]
Journal of the Egyptian Society of Parasitology, 2020 Toxoplasma gondii is an opportunistic protozoan that causes a devastating disease in immunocompromisedindividuals and congenitally infected neonates or children.
GEHAN A. RASHED +7 more
doaj +1 more source
Azithromycin treatment failure and macrolide resistance in Mycoplasma genitalium infections in Sofia, Bulgaria [PDF]
Folia Medica, 2022 Introduction: Mycoplasma genitalium is an established cause of sexually transmitted infections in men and women. Current guidelines recommend azithromycin and moxifloxacin as first- and second-line treatment, respectively. However, azithromycin treatment
Ivva Philipova +3 more
doaj +3 more sources
Dry Powder Formulation of Azithromycin for COVID-19 Therapeutics [PDF]
, 2023 Aim: The aim of this study is to develop dry powder formulations of azithromycin-loaded poly(lactic-co-glycolic acid) (PLGA) nanocomposite microparticles for pulmonary delivery to improve the low bioavailability of azithromycin.
Somavarapu, Satyanarayana +3 more
core +1 more source